VPS35 and Parkinson disease: In addition, it has been proposed that VPS35 deficiency or mutation decreases the degradation of α-syn and contributes to the pathogenesis of PD by impairing CMA in dopaminergic neurons, primarily by limiting the retrieval of LAMP2A from endosomes to the Golgi[49].